Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2

3(50.0%)

N/A

2(33.3%)

Phase 3

1(16.7%)

6Total

Phase 2(3)

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05516069Not ApplicableRecruiting

Our Healthbox - Evaluating Interactive Dispensing Systems for Low-Barrier Access to HIV Testing and Harm Reduction.

Role: collaborator

NCT00289952Phase 2Completed

Valproic Acid and Its Effects on HIV Latent Reservoirs

Role: collaborator

NCT04514848Not ApplicableCompleted

Point of Care Tests for Syphilis and HIV

Role: collaborator

NCT00188292Completed

Screening for HIV-Associated Anal Cancer

Role: collaborator

NCT02166502Completed

Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection

Role: collaborator

NCT00691288Phase 2Terminated

Effect of Omega-3 Fatty Acid Supplementation on Hypertriglyceridemia in HIV-infected Children

Role: collaborator

NCT00152893Phase 2Completed

To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities

Role: collaborator

NCT00529971Phase 3Completed

A Randomized Controlled Trial of a Mindfulness-Based Stress Reduction Intervention for Men Living With HIV

Role: collaborator

All 8 trials loaded